13F HOLDINGS REPORT
Sofinnova Investments, Inc.
Quarter ended Q2 2023 · Filed May 11, 2023 · Accession 0001104659-23-058987
Total Value
$1.56B
Positions
53
Other Managers
0
Confidential Omitted
No
Holdings (53)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Karuna Therapeutics Inc | 48576A100 | 1,772,441 | $321.9M | 20.59% |
| 2 | Natera Inc | NTRA | 3,100,560 | $172.1M | 11.01% |
| 3 | Merck & Co Inc | MRK | 841,522 | $89.5M | 5.73% |
| 4 | SPDR S&P 500 ETF Trust | SPY | 200,000 | $81.9M | 5.24% |
| 5 | Ascendis Pharma A/S | ASND | 754,032 | $80.8M | 5.17% |
| 6 | Aerovate Therapeutics Inc | 008064107 | 3,758,686 | $75.8M | 4.85% |
| 7 | Reata Pharmaceuticals Inc | 75615P103 | 627,683 | $57.1M | 3.65% |
| 8 | Eli Lilly and Co | LLY | 137,100 | $47.1M | 3.01% |
| 9 | Horizon Therapeutics PLC | G46188101 | 408,819 | $44.6M | 2.85% |
| 10 | Intuitive Surgical Inc | ISRG | 149,589 | $38.2M | 2.44% |
| 11 | Biogen Inc | BIIB | 132,600 | $36.9M | 2.36% |
| 12 | Biomarin Pharmaceutical Inc | BMRN | 359,035 | $34.9M | 2.23% |
| 13 | Dexcom Inc | DXCM | 257,227 | $29.9M | 1.91% |
| 14 | Travere Therapeutics Inc | TVTX | 1,263,721 | $28.4M | 1.82% |
| 15 | Vera Therapeutics Inc | VERA | 3,467,156 | $26.9M | 1.72% |
| 16 | PTC Therapeutics Inc | PTCT | 517,095 | $25.0M | 1.60% |
| 17 | Zentalis Pharmaceuticals Inc | ZNTL | 1,439,062 | $24.8M | 1.58% |
| 18 | Inhibrx Inc | INBX | 1,244,488 | $23.5M | 1.50% |
| 19 | Chinook Therapeutics Inc | 16961L106 | 1,002,348 | $23.2M | 1.48% |
| 20 | Syndax Pharmaceuticals Inc | SNDX | 1,075,424 | $22.7M | 1.45% |
| 21 | IVERIC bio Inc | 46583P102 | 905,982 | $22.0M | 1.41% |
| 22 | Immatics NV | IMTX | 3,132,694 | $21.6M | 1.38% |
| 23 | Inozyme Pharma Inc | 45790W108 | 3,655,308 | $20.9M | 1.34% |
| 24 | Geron Corp | GERN | 8,274,892 | $18.0M | 1.15% |
| 25 | Sarepta Therapeutics Inc | SRPT | 119,065 | $16.4M | 1.05% |
| 26 | Exelixis Inc | EXEL | 831,243 | $16.1M | 1.03% |
| 27 | Vir Biotechnology Inc | VIR | 657,559 | $15.3M | 0.98% |
| 28 | Celldex Therapeutics Inc | CLDX | 419,397 | $15.1M | 0.97% |
| 29 | Prometheus Biosciences Inc | 74349U108 | 123,842 | $13.3M | 0.85% |
| 30 | Cytokinetics Inc | CYTK | 353,796 | $12.5M | 0.80% |
| 31 | CTI Biopharma Corp | 12648L601 | 2,794,542 | $11.7M | 0.75% |
| 32 | Y-mAbs Therapeutics Inc | 984241109 | 2,194,278 | $11.0M | 0.70% |
| 33 | Agenus Inc | AGEN | 6,407,457 | $9.7M | 0.62% |
| 34 | Marinus Pharmaceuticals Inc | 56854Q200 | 1,200,389 | $8.3M | 0.53% |
| 35 | Galera Therapeutics Inc | GRTX | 3,083,712 | $7.9M | 0.50% |
| 36 | Kura Oncology Inc | KURA | 616,169 | $7.5M | 0.48% |
| 37 | Axsome Therapeutics Inc | AXSM | 120,896 | $7.5M | 0.48% |
| 38 | IDEAYA Biosciences Inc | IDYA | 453,149 | $6.2M | 0.40% |
| 39 | Nucana PLC | NCNA | 5,599,999 | $5.4M | 0.34% |
| 40 | Revolution Medicines Inc | RVMDW | 183,838 | $4.0M | 0.25% |
| 41 | Nextcure Inc | NXTC | 2,671,856 | $4.0M | 0.25% |
| 42 | ImmunoGen Inc | 45253H101 | 1,000,000 | $3.8M | 0.25% |
| 43 | Bolt Biotherapeutics Inc | BOLT | 2,754,437 | $3.8M | 0.24% |
| 44 | ImmunoGen Inc | 45253H101 | 924,532 | $3.6M | 0.23% |
| 45 | Keros Therapeutics Inc | KROS | 77,100 | $3.3M | 0.21% |
| 46 | Novocure Ltd | NVCR | 50,000 | $3.0M | 0.19% |
| 47 | Nucana PLC | NCNA | 2,400,000 | $2.3M | 0.15% |
| 48 | bluebird bio Inc | 09609G100 | 672,815 | $2.1M | 0.14% |
| 49 | PDS Biotechnology Corp | PDSB | 142,635 | $877,205 | 0.06% |
| 50 | Fusion Pharmaceuticals Inc | 36118A100 | 117,099 | $441,463 | 0.03% |
| 51 | Synlogic Inc | SYBX | 574,972 | $363,382 | 0.02% |
| 52 | Karuna Therapeutics Inc | 48576A100 | 683 | $124,060 | 0.01% |
| 53 | Alnylam Pharmaceuticals Inc | ALNY | 448 | $89,743 | 0.01% |